CERO THERAPEUTICS HOLDINGS, INC. Interest Expense Operating
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Interest Expense Operating of $71.14 thousand for the 2-month period ending 2024-03-31, per its 10-Q filed 2024-05-17.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOperating · last filed 2024-05-17
- 2024-03-31: Interest Expense Operating 2 month $71.14K.
- 2024-02-13: Interest Expense Operating 1 month $28.31K.
| Period end | Interest Expense Operating 1 month | Interest Expense Operating 2 month |
|---|---|---|
| 2024-03-31 | $71.14K 10-Q · filed 2024-05-17 | |
| 2024-02-13 | $28.31K 10-Q · filed 2024-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |